BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1755317)

  • 1. Morphological and cytogenetic characterization and N-myc oncogene analysis of a newly established neuroblastoma cell line.
    Nojima T; Abe S; Furuta Y; Nagashima K; Alam AF; Takada N; Sasaki F; Hata Y
    Acta Pathol Jpn; 1991 Jul; 41(7):507-15. PubMed ID: 1755317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human neuroblastoma cell lines that express N-myc without gene amplification.
    Wada RK; Seeger RC; Brodeur GM; Einhorn PA; Rayner SA; Tomayko MM; Reynolds CP
    Cancer; 1993 Dec; 72(11):3346-54. PubMed ID: 8242562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of a continuous cell line (MHH-NB-11) derived from advanced neuroblastoma.
    Pietsch T; Göttert E; Meese E; Blin N; Feickert HJ; Riehm H; Kovacs G
    Anticancer Res; 1988; 8(6):1329-33. PubMed ID: 3218965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytogenetic and molecular characterization of a newly established neuroblastoma cell line LS.
    Rudolph G; Schilbach-Stückle K; Handgretinger R; Kaiser P; Hameister H
    Hum Genet; 1991 Apr; 86(6):562-6. PubMed ID: 2026421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Establishment and characterization of human neuroblastoma cell line (HSNB)].
    Ono I; Ishiwata I; Nakaguchi T; Ohara K; Tokita N; Soma M; Ishiwata C; Nozawa S; Ishikawa H
    Hum Cell; 1989 Dec; 2(4):416-22. PubMed ID: 2486666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged N-myc protein half-life in a neuroblastoma cell line lacking N-myc amplification.
    Cohn SL; Salwen H; Quasney MW; Ikegaki N; Cowan JM; Herst CV; Kennett RH; Rosen ST; DiGiuseppe JA; Brodeur GM
    Oncogene; 1990 Dec; 5(12):1821-7. PubMed ID: 2284101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. S-cells from a highly N-myc-amplified neuroblastoma are tumorigenic in nude mice.
    Sleight BJ; Soukup S; Ballard ET; Parysek LM
    Anticancer Res; 1993; 13(6A):2031-6. PubMed ID: 8297111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromosomal localization of amplified N-myc in neuroblastoma cells using a biotinylated probe.
    Rudduck C; Lukeis RE; McRobert TL; Chow CW; Garson OM
    Cancer Genet Cytogenet; 1992 Jan; 58(1):55-9. PubMed ID: 1728951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolution of tumor cytogenetic aberrations and N-myc oncogene amplification in a case of disseminated neuroblastoma.
    Christiansen H; Franke F; Bartram CR; Adolph S; Rudolph B; Harbott J; Reiter A; Lampert F
    Cancer Genet Cytogenet; 1987 Jun; 26(2):235-44. PubMed ID: 3567877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural features of the amplified N-myc oncogene detected by micrococcal nuclease digestion of neuroblastoma cell nuclei.
    Telford DJ; Stewart BW
    Biochem Int; 1990 Sep; 21(6):1025-32. PubMed ID: 2080918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A neuroblastoma cell line derived from a case detected through a mass screening system in Japan: a case report including the biologic and phenotypic characteristics of the cell line.
    Hiraiwa H; Hamazaki M; Takata A; Kikuchi H; Hata J
    Cancer; 1997 May; 79(10):2036-44. PubMed ID: 9149033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment and characterization of a human neuroblastoma cell line.
    Scarpa S; Dominici C; Grammatico P; Del Porto G; Raschellà G; Castello M; Forni G; Modesti A
    Int J Cancer; 1989 Apr; 43(4):645-51. PubMed ID: 2703273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MYCN amplification and 17q in neuroblastoma: evidence for structural association.
    O'Neill S; Ekstrom L; Lastowska M; Roberts P; Brodeur GM; Kees UR; Schwab M; Bown N
    Genes Chromosomes Cancer; 2001 Jan; 30(1):87-90. PubMed ID: 11107180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bi-modal differentiation pattern in a new human neuroblastoma cell line in vitro.
    Matsushima H; Bogenmann E
    Int J Cancer; 1992 May; 51(2):250-8. PubMed ID: 1568793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth patterns of human neuroblastoma xenografts and their relationship to treatment outcome.
    George BA; Yanik G; Wells RJ; Martin LW; Soukup S; Ballard ET; Gartside PS; Lampkin BC
    Cancer; 1993 Dec; 72(11):3331-9. PubMed ID: 8242560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroblastoma with DNA amplification and rearrangement in the N-myc gene region.
    Hiyama E; Hiyama K; Yokoyama T
    Cancer Res; 1991 Apr; 51(7):1946-51. PubMed ID: 2004381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coactivation of the MDR1 and MYCN genes in human neuroblastoma cells during the metastatic process in the nude mouse.
    Ferrandis E; Da Silva J; Riou G; Bénard I
    Cancer Res; 1994 Apr; 54(8):2256-61. PubMed ID: 8174136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of N-myc gene amplification in bone marrow specimen of stage IV neuroblastoma patients.
    Brack T; Scholz RB; Milde-Langosch K; Heinsohn S; Löning T; Kabisch H
    Cancer Detect Prev; 1992; 16(3):185-92. PubMed ID: 1458508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stability of phenotypic and genotypic traits during the establishment of a human neuroblastoma cell line, IGR-N-835.
    Bettan-Renaud L; Bayle C; Teyssier JR; Benard J
    Int J Cancer; 1989 Sep; 44(3):460-6. PubMed ID: 2777412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extensive genetic heterogeneity in the neuroblastoma cell line NB(TU)1.
    Inoue A; Yokomori K; Tanabe H; Mizusawa H; Sofuni T; Hayashi Y; Tsuchida Y; Shimatake H
    Int J Cancer; 1997 Sep; 72(6):1070-7. PubMed ID: 9378542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.